Bariatric Surgery Outcomes in Patients with Inflammatory Bowel Disease in the United States: An Analysis of the Nationwide Readmissions Database - Scorecard - MDSpire

Bariatric Surgery Outcomes in Patients with Inflammatory Bowel Disease in the United States: An Analysis of the Nationwide Readmissions Database

  • By

  • Noah C. Wilson

  • Danielle B. Dilsaver

  • Ryan W. Walters

  • Kalyana C. Nandipati

  • February 27, 2024

  • 0 min

Share

Clinical Scorecard: Outcomes of Bariatric Surgery in Individuals with Inflammatory Bowel Disease in the United States: Insights from the Nationwide Readmissions Database

At a Glance

CategoryDetail
ConditionObesity and Inflammatory Bowel Disease (IBD) including Crohn’s disease and ulcerative colitis
Key MechanismsPotential shared proinflammatory molecular pathways linking obesity and IBD; bariatric surgery as a therapeutic intervention for obesity
Target PopulationAdults with obesity undergoing sleeve gastrectomy, with or without comorbid IBD
Care SettingInpatient hospital setting in the United States

Key Highlights

  • Obesity prevalence in US adults exceeds 40%, with significant associated health and economic burdens.
  • Approximately one-third of patients with IBD also suffer from obesity, suggesting overlapping inflammatory mechanisms.
  • Sleeve gastrectomy is a common bariatric procedure with limited data on safety and readmission outcomes in patients with IBD.

Guideline-Based Recommendations

Diagnosis

  • Identify obesity and IBD diagnoses using ICD-9 and ICD-10 codes in hospital records.
  • Use Medicare Severity Diagnosis Related Groups (MS-DRG) codes to identify bariatric surgery hospitalizations.

Management

  • Consider sleeve gastrectomy as a primary surgical option for obesity management in patients with and without IBD.
  • Exclude patients under 18 years or with prior bariatric surgery from surgical candidacy for sleeve gastrectomy.

Monitoring & Follow-up

  • Monitor in-hospital mortality and post-operative complications using ICD codes during index hospitalization.
  • Track all-cause and cause-specific 90-day readmission rates within the same calendar year post-discharge.

Risks

  • Recognize potential increased risk of post-operative complications and readmissions in patients with comorbid IBD.
  • Account for limitations in outpatient outcome data and readmission tracking across calendar years.

Patient & Prescribing Data

Adults undergoing sleeve gastrectomy for obesity, stratified by presence or absence of IBD

Sleeve gastrectomy shows favorable weight loss outcomes; safety and readmission profiles require further evaluation in IBD patients.

Clinical Best Practices

  • Utilize comprehensive inpatient databases like the Nationwide Readmissions Database for outcome assessment.
  • Incorporate Elixhauser comorbidity indices to adjust for co-existing conditions affecting surgical outcomes.
  • Exclude patients discharged late in the calendar year to ensure complete 90-day follow-up for readmission analysis.

References

Original Source(s)

Related Content